A four-year-old London start-up backed by Peter Thiel has raised a $55 million Series B round as it sets about “fixing the broken clinical trial industry.” The an...

Ever since the gene responsible for cystic fibrosis was discovered 25 years ago, scientists have envisaged gene therapies to correct the underlying genetic defect. ...

CVS Health has said it will beef up its clinical trials operations, improving its ability to recruit patients from a broad demographic spectrum, via an agreement wit...

A new £7m clinical trial research centre for more than four million people, including those in deprived areas of the West Midlands, will transform health outcomes, N...

Qureight Ltd, the Core Imaging Laboratory developing deep-learning image analytics, and Avalyn Pharma Inc., a clinical-stage biopharmaceutical company focused on dev...

In a global first, Uganda’s Ministry of Health, the World Health Organization (WHO) and other partners today launched a first-ever clinical efficacy trial for a vacc...

Cell and Gene Therapy Catapult reveals significant growth in UK trials The UK experienced a notable increase in advanced therapy clinical trials in 2024, reaching...

CR-discovered NXP800 shows promise in clinical trials Prostate cancer resistant to hormone therapy could soon have a new treatment option. The Institute of Can...

The National Institute for Health and Care Excellence (NICE) has today approved a gene-editing treatment for use with NHS patients over the age of 12 with a severe f...

Patients with pancreatic cancer are being offered new hope with a number of clinical trials into promising treatments opening at the Royal Free London.  Sadl...